Overview

Clinical Trial to Evaluate the Chronic Efficacy of OC-01 Nasal Spray on Signs of Dry Eye Disease (The MYSTIC Study)

Status:
Completed
Trial end date:
2020-01-07
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the chronic safety and effectiveness of OC-01 Nasal Spray as compared to placebo on signs of dry eye disease (DED).
Phase:
Phase 2
Details
Lead Sponsor:
Oyster Point Pharma, Inc.